Start Your Weight Loss Journey Today With the same active ingredient as Ozempic, our semaglutide-based medical weight loss program offers a proven path to success
Surgery carries: Operative risks Potential long-term nutritional deficiencies Requires lifelong follow-up Weighing Non-Invasive Peptide Therapy Against Bariatric Surgery in Obesity Management Peptide therapy, including tirzepatide peptide drugs, offers significant, sometimes comparable weight loss without surgery, but it usually requires ongoing treatment to maintain the effect
By leveraging trained and certified coders, you gain access to: Accurate and up-to-date coding for injections and all other services Compliance with CMS and private payor guidelines Real-time denial management and claims tracking Custom reporting and analytics to monitor CPT code usage Support for multiple specialties, from primary care to urgent care and pain management Reimbursement Considerations The average Medicare reimbursement for CPT 96372 (2025 rates may vary by locality) is approximately $15$25, depending on the providers fee schedule
Viking Therapeutics, a San Diego, California-based clinical-stage bio/pharmaceutical company, is advancing a dual GLP-1/GIP agonist, VK2735, for treating obesity for both subcutaneous and oral administration
While an auto-injector may seem convenient, vial dosing allows you to receive the exact amount of medication that meets your needs, something an auto-injector cant do